Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · IEX Real-Time Price · USD
-0.25 (-1.30%)
Apr 16, 2024, 4:00 PM EDT - Market closed

Myriad Genetics Statistics

Total Valuation

MYGN has a market cap or net worth of $1.70 billion. The enterprise value is $1.71 billion.

Market Cap 1.70B
Enterprise Value 1.71B

Important Dates

The next estimated earnings date is Wednesday, May 1, 2024, after market close.

Earnings Date May 1, 2024
Ex-Dividend Date n/a

Share Statistics

MYGN has 89.87 million shares outstanding. The number of shares has increased by 2.73% in one year.

Shares Outstanding 89.87M
Shares Change (YoY) +2.73%
Shares Change (QoQ) +5.49%
Owned by Insiders (%) 2.01%
Owned by Institutions (%) 103.03%
Float 74.68M

Valuation Ratios

PE Ratio n/a
Forward PE 646.76
PS Ratio 2.26
Forward PS 2.02
PB Ratio 2.17
P/FCF Ratio n/a
PEG Ratio 1.40
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.27
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.19.

Current Ratio 2.01
Quick Ratio 1.64
Debt / Equity 0.19
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -89.41

Financial Efficiency

Return on equity (ROE) is -34.70% and return on invested capital (ROIC) is -27.52%.

Return on Equity (ROE) -34.70%
Return on Assets (ROA) -22.60%
Return on Capital (ROIC) -27.52%
Revenue Per Employee $278,963
Profits Per Employee -$97,519
Employee Count 2,700
Asset Turnover 0.65
Inventory Turnover 11.22


In the past 12 months, MYGN has paid $1.10 million in taxes.

Income Tax 1.10M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -13.96% in the last 52 weeks. The beta is 1.98, so MYGN's price volatility has been higher than the market average.

Beta (1Y) 1.98
52-Week Price Change -13.96%
50-Day Moving Average 21.79
200-Day Moving Average 19.35
Relative Strength Index (RSI) 33.10
Average Volume (30 Days) 620,320

Short Selling Information

The latest short interest is 5.67 million, so 6.30% of the outstanding shares have been sold short.

Short Interest 5.67M
Short Previous Month 4.80M
Short % of Shares Out 6.30%
Short % of Float 7.59%
Short Ratio (days to cover) 7.73

Income Statement

In the last 12 months, MYGN had revenue of $753.20 million and -$263.30 million in losses. Loss per share was -$3.18.

Revenue 753.20M
Gross Profit 517.00M
Operating Income -257.40M
Pretax Income -262.20M
Net Income -263.30M
EBITDA -186.10M
EBIT -259.30M
Loss Per Share -$3.18
Full Income Statement

Balance Sheet

The company has $140.90 million in cash and $152.10 million in debt, giving a net cash position of -$11.20 million or -$0.12 per share.

Cash & Cash Equivalents 140.90M
Total Debt 152.10M
Net Cash -11.20M
Net Cash Per Share -$0.12
Equity / Book Value 783.20M
Book Value Per Share 8.71
Working Capital 157.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$110.90 million and capital expenditures -$73.30 million, giving a free cash flow of -$184.20 million.

Operating Cash Flow -110.90M
Capital Expenditures -73.30M
Free Cash Flow -184.20M
FCF Per Share -$2.23
Full Cash Flow Statement


Gross margin is 68.64%, with operating and profit margins of -34.17% and -34.96%.

Gross Margin 68.64%
Operating Margin -34.17%
Pretax Margin -34.81%
Profit Margin -34.96%
EBITDA Margin -24.71%
EBIT Margin -34.43%
FCF Margin -24.46%

Dividends & Yields

MYGN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -2.73%
Shareholder Yield -2.73%
Earnings Yield -15.50%
FCF Yield -10.84%
Dividend Details

Analyst Forecast

The average price target for MYGN is $22.50, which is 18.92% higher than the current price. The consensus rating is "Buy".

Price Target $22.50
Price Target Difference 18.92%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 9.35%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on March 26, 2009. It was a forward split with a ratio of 2:1.

Last Split Date Mar 26, 2009
Split Type Forward
Split Ratio 2:1


MYGN has an Altman Z-Score of 2.11 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.11
Piotroski F-Score 3